Iridex (IRIX) EPS (Diluted) Growth (1y) (2011 - 2026)
Iridex (IRIX) EPS (Diluted) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 13.96% |
| 10 | Iridex | 13.27 Mn | 8.59 Mn | 4.30 Mn | -22.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 69.97% |
| Jan 3, 2026 | 78.51% |
| Sep 27, 2025 | 20.67% |
| Jun 28, 2025 | 64.01% |
| Mar 29, 2025 | 52.71% |
| Dec 28, 2024 | -112.14% |
| Sep 28, 2024 | -7.88% |
| Jun 29, 2024 | 4.64% |
| Mar 30, 2024 | -63.17% |
| Dec 30, 2023 | 3.72% |
| Sep 30, 2023 | 2.23% |
| Jul 1, 2023 | -22.33% |
| Apr 1, 2023 | 13.24% |
| Dec 31, 2022 | 569.03% |
| Oct 1, 2022 | 19.21% |
| Jul 2, 2022 | -265.06% |
| Apr 2, 2022 | -7.46% |
| Oct 2, 2021 | -10.58% |
| Jul 3, 2021 | 142.38% |
| Apr 3, 2021 | -16.99% |